Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,637Revenue $M318Net Margin (%)5.1Z-Score2.4
Enterprise Value $M5,652EPS $0.5Operating Margin %12.6F-Score5
P/E(ttm))236Cash Flow Per Share $0.4Pre-tax Margin (%)8.3Higher ROA y-yN
Price/Book14.010-y EBITDA Growth Rate %0Quick Ratio2.7Cash flow > EarningsY
Price/Sales11.15-y EBITDA Growth Rate %0Current Ratio3.7Lower Leverage y-yN
Price/Cash Flow31.6y-y EBITDA Growth Rate %1.2ROA % (ttm)2.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)8.4Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M108ROI % (ttm)12.4Gross Margin Increase y-yN

Gurus Latest Trades with AKRX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AKRXJoel Greenblatt 2014-09-30 Reduce-0.01%$32.14 - $39.09
($35.91)
$ 4320%Reduce -37.69%24,479
AKRXMario Gabelli 2014-06-30 Reduce$20.93 - $31.71
($26.11)
$ 4365%Reduce -37.42%9,950
AKRXJoel Greenblatt 2014-06-30 Reduce-0.01%$20.93 - $31.71
($26.11)
$ 4365%Reduce -42.33%39,285
AKRXJoel Greenblatt 2014-03-31 Add0.02%$21 - $27.81
($23.43)
$ 4384%Add 283.01%68,119
AKRXMario Gabelli 2014-03-31 Buy $21 - $27.81
($23.43)
$ 4384%New holding, 15900 sh.15,900
AKRXJoel Greenblatt 2013-12-31 Reduce-0.01%$19.44 - $25.76
($22.61)
$ 4390%Reduce -41.04%17,785
AKRXJoel Greenblatt 2013-09-30 Buy 0.02%$13.43 - $19.3
($16.16)
$ 43166%New holding, 30162 sh.30,162
AKRXGeorge Soros 2011-12-31 Sold Out -0.002%$7.45 - $11.48
($9.48)
$ 43354%Sold Out0
AKRXGeorge Soros 2011-09-30 Buy $6.75 - $9.22
($7.83)
$ 43449%New holding, 14900 sh.14,900
AKRXMichael Price 2010-06-30 Sold Out -0.09%$1.38 - $3.21
($2.49)
$ 431627%Sold Out0
AKRXMichael Price 2010-03-31 Add0.03%$1.33 - $1.87
($1.6)
$ 432588%Add 43.88%292,800
AKRXMichael Price 2009-12-31 Buy 0.1%$1.23 - $1.91
($1.61)
$ 432571%New holding, 203501 sh.203,501
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AKRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AKRX Mario Gabelli 2014-09-309,3000.010-6.53%
AKRX Joel Greenblatt 2014-09-3024,4790.020.01-37.69%
Premium Most recent portfolio changes are included for Premium Members only!


AKRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Silverberg Mark MExec VP, Ops Global QA&TechSrv 2015-01-12Sell38,602$413.12view
JOHNSON RONALD MDirector 2015-01-09Sell17,173$40.464.5view
JOHNSON RONALD MDirector 2015-01-02Sell14,300$36.1217.05view
JOHNSON RONALD MDirector 2015-01-02Sell14,300$36.1217.05view
Dick Timothy ACFO 2015-01-02Sell30,150$36.0317.35view
Tambi BrianDirector 2014-12-15Sell1,200$41.861view
Graves Adrienne LDirector 2014-12-12Sell9,557$41.092.9view
KAPOOR JOHN NDirector, 10% Owner 2014-12-11Sell50,000$41.192.65view
Sabat John RSr. V.P. National Accts Sales 2014-12-09Sell43,173$40.534.32view
Dick Timothy ACFO 2014-12-01Sell30,875$39.237.77view

Press Releases about AKRX :

    Quarterly/Annual Reports about AKRX:

    News about AKRX:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Akorn Inc, Under Armour Inc, Anadarko Petroleum Corp, and Graphic Packag Aug 09 2014 
    WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
    Weekly CFO Sells Highlight: ASGN, COF, AKRX, MCRS, GILD, ROP, PLL Sep 24 2012 
    5 Healthcare Picks for 2012 Mar 21 2012 
    Weekly CFO Sells Highlight: AN, CATM, AKRX, NNN, FTNT Aug 28 2011 
    Akorn Inc. (AKRX) CFO Timothy A Dick buys 3,900 Shares Aug 16 2010 
    Akorn Inc. Reports Operating Results (10-Q) May 10 2010 
    Akorn Inc. Reports Operating Results (10-Q) Nov 09 2009 
    Weekly CFO Buy Highlights: Gigatronics Inc., Akorn Inc., MainSource Financial Group Inc, U.S. Auto P Sep 06 2009 
    Akorn Inc. Reports Operating Results (10-Q) Aug 17 2009 

    More From Other Websites
    Lannett Early Q2 Earnings Beat Estimates; Stock Jumps Jan 26 2015
    Will New FDA Approvals Boost Leading Drug Stock Akorn? Jan 22 2015
    Akorn Receives FDA Approval for Phenylephrine HCl Ophthalmic Solution Jan 20 2015
    Will Akorn (AKRX) Continue to Surge Higher? - Tale of the Tape Jan 19 2015
    Akorn Confirms Generic Durezol(R) Patent Challenge Jan 15 2015
    3 Reasons To Be Bullish On Generic Drug Firm Akorn Jan 15 2015
    Citadel Advisors decreases position in Apple Jan 14 2015
    Citadel Advisors adds position in Actavis Plc Jan 14 2015
    Citadel Advisors exits position in Akorn, Inc. Jan 13 2015
    Citadel Advisors adds new position in Workday, Inc. Jan 13 2015
    Akorn Sees Strong Pricing In Generic Drugs Jan 12 2015
    Four Best Gains In IBD 50: Nothing To Do With Oil Jan 09 2015
    Stock Market Surges; Nasdaq, S&P 500 Retake 50-Day Lines Jan 08 2015
    Stocks Pounded As Oil Drops Below $50 A Barrel Jan 05 2015
    Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference Dec 19 2014
    Stocks Mixed In Volatile Session; Boeing Boosts Dow Dec 16 2014
    Great Stocks: Drugmaker Akorn Works On Base Dec 15 2014
    Why Akorn (AKRX) is Poised to Beat Earnings Estimates Again Dec 15 2014
    AKORN INC Files SEC form 8-K/A, Financial Statements and Exhibits Dec 12 2014
    Coverage initiated on Akorn by William Blair Dec 09 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK